Critical issues in chemotherapy with tiazofurin
- 31 December 1989
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 29, 75-95
- https://doi.org/10.1016/0065-2571(89)90095-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenaseBiochemistry, 1988
- Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activityAdvances in Enzyme Regulation, 1983
- Inhibition of inosinate dehydrogenase by metabolites of 2-β-D-ribofuranosylthiazole-4-car☐amideBiochemical and Biophysical Research Communications, 1982
- Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193)Biochemical Pharmacology, 1982
- The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory propertiesBiochemical Pharmacology, 1982
- 2-.beta.-D-ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastasesJournal of Medicinal Chemistry, 1982
- Nucleoside and Nucleotide Inhibitors of Inosine Monophosphate (IMP) Dehydrogenase as Potential Antitumor InhibitorsNucleosides and Nucleotides, 1982
- Enzymology of Cancer CellsNew England Journal of Medicine, 1977
- Enzymology of Cancer CellsNew England Journal of Medicine, 1977
- Key enzymes of IMP metabolism: Transformation- and proliferation-linked alterations in gene expressionAdvances in Enzyme Regulation, 1976